LV12251B - 2-fenil-1,2-benzizoselenazol-3(2h)-ona pielietojums medikamenta ražošanai, kas paredzēts alcheimera slimības profilaksei un/vai terapijai - Google Patents

2-fenil-1,2-benzizoselenazol-3(2h)-ona pielietojums medikamenta ražošanai, kas paredzēts alcheimera slimības profilaksei un/vai terapijai Download PDF

Info

Publication number
LV12251B
LV12251B LVP-98-231A LV980231A LV12251B LV 12251 B LV12251 B LV 12251B LV 980231 A LV980231 A LV 980231A LV 12251 B LV12251 B LV 12251B
Authority
LV
Latvia
Prior art keywords
die
der
alzheimer
verbindung
das
Prior art date
Application number
LVP-98-231A
Other languages
English (en)
Latvian (lv)
Other versions
LV12251A (lv
Inventor
Ikuo Maruyama
Kazuhiro Abeyama
Hiroyuki Masayasu
Original Assignee
A.Nattermann & Cie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A.Nattermann & Cie Gmbh filed Critical A.Nattermann & Cie Gmbh
Publication of LV12251A publication Critical patent/LV12251A/xx
Publication of LV12251B publication Critical patent/LV12251B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
LVP-98-231A 1996-08-27 1998-10-22 2-fenil-1,2-benzizoselenazol-3(2h)-ona pielietojums medikamenta ražošanai, kas paredzēts alcheimera slimības profilaksei un/vai terapijai LV12251B (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22551296 1996-08-27
PCT/DE1997/000701 WO1998008511A1 (de) 1996-08-27 1997-04-07 Verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-one zur herstellung einer pharmazeutischen zubereitung für die behandlung der alzheimer-krankheit

Publications (2)

Publication Number Publication Date
LV12251A LV12251A (lv) 1999-04-20
LV12251B true LV12251B (lv) 1999-08-20

Family

ID=16830487

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-98-231A LV12251B (lv) 1996-08-27 1998-10-22 2-fenil-1,2-benzizoselenazol-3(2h)-ona pielietojums medikamenta ražošanai, kas paredzēts alcheimera slimības profilaksei un/vai terapijai

Country Status (29)

Country Link
US (1) US5948800A (cs)
EP (1) EP0826370B1 (cs)
KR (1) KR20000035859A (cs)
CN (1) CN1112922C (cs)
AT (1) ATE219361T1 (cs)
AU (2) AU3866997A (cs)
BR (1) BR9711259A (cs)
CA (1) CA2213794C (cs)
CZ (1) CZ295364B6 (cs)
DE (2) DE59707550D1 (cs)
DK (1) DK0826370T3 (cs)
EE (1) EE03953B1 (cs)
ES (1) ES2177849T3 (cs)
FI (1) FI119622B (cs)
HK (1) HK1020317A1 (cs)
HU (1) HU225264B1 (cs)
IL (1) IL127113A (cs)
LT (1) LT4602B (cs)
LV (1) LV12251B (cs)
NO (1) NO312812B1 (cs)
NZ (1) NZ332292A (cs)
PL (1) PL188481B1 (cs)
PT (1) PT826370E (cs)
SI (1) SI9720060B (cs)
TR (1) TR199700858A2 (cs)
TW (1) TW501925B (cs)
UA (1) UA59367C2 (cs)
WO (2) WO1998008511A1 (cs)
ZA (1) ZA977644B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2143898C1 (ru) * 1993-10-27 2000-01-10 Дайити Фармасьютикал Ко., Лтд. Гранулированный фармацевтический препарат и водная суспензия на его основе
JP2000016935A (ja) * 1998-07-01 2000-01-18 Dai Ichi Seiyaku Co Ltd シクロオキシゲナーゼ阻害剤
WO2000058281A1 (fr) * 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrats pour thioredoxine reductase
WO2003010154A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
WO2003010153A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
WO2003010143A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
CN103965188A (zh) * 2013-01-29 2014-08-06 中山大学 含硒多奈哌齐类似物
EP2950102A1 (en) 2014-05-30 2015-12-02 Biocross, S.L. Method for the diagnosis of alzheimer s disease and mild cognitive impairment
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
EP3067699A1 (en) 2015-03-11 2016-09-14 Neuron Bio, S.A. Method for diagnosing alzheimer's disease
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
CN113116888B (zh) * 2021-04-19 2022-08-26 上海兴糖生物技术有限公司 依布硒啉的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3638124C2 (de) * 1986-11-08 1996-09-05 Nattermann A & Cie Neue pharmazeutische Verwendung von Ebselen
JPH01131113A (ja) * 1987-08-27 1989-05-24 Dai Ichi Seiyaku Co Ltd 脳障害治療剤
JPH0238591A (ja) 1988-07-27 1990-02-07 Fujikura Ltd 高純度銅の製造方法
US5385726A (en) * 1990-08-06 1995-01-31 Rhone-Poulenc Rorer Gmbh Use of 2-phenyl-1,2-benzisoselenazol-3-(2H)-one
DE4024885C2 (de) * 1990-08-06 2002-07-18 Nattermann A & Cie Verwendung von 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
FR2669633B1 (fr) * 1990-11-23 1993-01-22 Adir Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH07233056A (ja) * 1993-09-03 1995-09-05 Dai Ichi Seiyaku Co Ltd リポキシゲナーゼ阻害剤

Also Published As

Publication number Publication date
ES2177849T3 (es) 2002-12-16
NO973912L (no) 1998-03-02
CN1223580A (zh) 1999-07-21
NO973912D0 (no) 1997-08-26
HUP9903213A3 (en) 2000-12-28
AU3529897A (en) 1998-03-05
TR199700858A2 (xx) 1998-03-21
UA59367C2 (uk) 2003-09-15
LT99016A (en) 1999-10-25
EP0826370B1 (de) 2002-06-19
ZA977644B (en) 1999-02-26
CA2213794C (en) 2006-10-03
EE03953B1 (et) 2003-02-17
NZ332292A (en) 2001-07-27
AU3866997A (en) 1998-03-19
DE19733690A1 (de) 1998-03-26
DK0826370T3 (da) 2002-10-07
CN1112922C (zh) 2003-07-02
IL127113A0 (en) 1999-09-22
SI9720060A (sl) 1999-06-30
WO1998008511A1 (de) 1998-03-05
CZ31799A3 (cs) 1999-11-17
TW501925B (en) 2002-09-11
NO312812B1 (no) 2002-07-08
WO1998008831A1 (fr) 1998-03-05
FI982689A0 (fi) 1998-12-11
FI119622B (fi) 2009-01-30
LV12251A (lv) 1999-04-20
IL127113A (en) 2003-07-06
KR20000035859A (ko) 2000-06-26
PL188481B1 (pl) 2005-02-28
DE59707550D1 (de) 2002-07-25
US5948800A (en) 1999-09-07
LT4602B (lt) 2000-01-25
SI9720060B (en) 2001-12-31
HUP9903213A1 (en) 2000-07-28
PL321796A1 (en) 1998-03-02
EE9900007A (et) 1999-06-15
PT826370E (pt) 2002-10-31
HK1020317A1 (en) 2000-04-14
FI982689A (fi) 1998-12-11
AU725534B2 (en) 2000-10-12
ATE219361T1 (de) 2002-07-15
BR9711259A (pt) 1999-08-17
EP0826370A1 (de) 1998-03-04
CZ295364B6 (cs) 2005-07-13
HU225264B1 (en) 2006-08-28
CA2213794A1 (en) 1998-02-27

Similar Documents

Publication Publication Date Title
DE69532031T2 (de) Schilddrüsenhormone enthaltende mittel
DE69930243T2 (de) Behandlung iatrogenen und altersbedingten bluthochdruck mit vitamin b6-derivative, und pharmazeutische zusammensetzungen verwendbar dazu
LV12251B (lv) 2-fenil-1,2-benzizoselenazol-3(2h)-ona pielietojums medikamenta ražošanai, kas paredzēts alcheimera slimības profilaksei un/vai terapijai
DE69401577T2 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
EP2072054B1 (de) Verwendung eines Extraktes aus Blättern von Ginkgo biloba
DE3877331T2 (de) Exifon und ein wasserloesliches polymer enthaltende pharmazeutische zubereitung.
DE4321444A1 (de) Pharmazeutische Zubereitung
DE3883606T2 (de) Verwendung von Fluoxetin zur Behandlung des Diabetes.
DE69433012T2 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
EP0591363A1 (de) Torasemid-haltige pharmazeutische zusammensetzungen
DE60308899T2 (de) Quaternäre verbindungen enthaltend propolis als wirkstoff
EP0164571B1 (de) Retardformen des alpha-(2,5-Dimethoxy-phenyl)-beta-lycinamido-äthanols und Verfahren zu ihrer Herstellung
DE3878169T2 (de) Medizinische zusammensetzungen, gegruendet auf flavonoiden und saponinen, gewonnen aus chrysanthellum, verfahren zu ihrer herstellung und therapeutische anwendungen.
DE3609005A1 (de) Pharmazeutische zusammensetzungen mit metabolischer aktivitaet
DE69004529T2 (de) Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
DE69121058T2 (de) Salze von Glykosaminoglykanen mit Aminosäureester, ihre Herstellung sowie sie enthaltende pharmazeutische Zusammensetzungen
WO2000001392B1 (de) 1-octadecyl-2-methyl-sn-glycero-3-phosphocholin (et180ch3) zur behandlung von humanen mammakarzinomen
DE2451933C2 (cs)
DE69029814T2 (de) Inhibitoren der dihydrofolatreduktase von pneumocystis carinii
DE2128730A1 (de) Mittel zur Kompensierung eines Dopaminmangels im Gehirn
EP0000015B1 (de) Arzneimittel zur Behandlung von Depressionen
DE2833014A1 (de) Antibiotisch wirksames mittel
EP0417637A2 (de) Verwendung von Dopamin-Autorezeptor-Agonisten bei der Behandlung von Drogenabhängigkeit
DE3439055A1 (de) Substituierte 4h-3,1 benzoxazine und ein benzodiazepin-derivat enthaltendes arzneimittel
DE4023136A1 (de) Neue galenische, orale form zur verbesserung der bioverfuegbarkeit von medikamenten